Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2018-09-01
|
Series: | ACS Omega |
Online Access: | http://dx.doi.org/10.1021/acsomega.8b01479 |
_version_ | 1818432711820312576 |
---|---|
author | Ravi K. Anchoori Rosie Jiang Shiwen Peng Ruey-shyang Soong Aliyah Algethami Michelle A. Rudek Nicole Anders Chien-Fu Hung Xiang Chen Xiuxiu Lu Olumide Kayode Marzena Dyba Kylie J. Walters Richard B. S. Roden |
author_facet | Ravi K. Anchoori Rosie Jiang Shiwen Peng Ruey-shyang Soong Aliyah Algethami Michelle A. Rudek Nicole Anders Chien-Fu Hung Xiang Chen Xiuxiu Lu Olumide Kayode Marzena Dyba Kylie J. Walters Richard B. S. Roden |
author_sort | Ravi K. Anchoori |
collection | DOAJ |
first_indexed | 2024-12-14T16:09:33Z |
format | Article |
id | doaj.art-ddb3d390b0824e9bb143313880ac9c72 |
institution | Directory Open Access Journal |
issn | 2470-1343 |
language | English |
last_indexed | 2024-12-14T16:09:33Z |
publishDate | 2018-09-01 |
publisher | American Chemical Society |
record_format | Article |
series | ACS Omega |
spelling | doaj.art-ddb3d390b0824e9bb143313880ac9c722022-12-21T22:55:01ZengAmerican Chemical SocietyACS Omega2470-13432018-09-0139119171192910.1021/acsomega.8b01479Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian CancerRavi K. Anchoori0Rosie Jiang1Shiwen Peng2Ruey-shyang Soong3Aliyah Algethami4Michelle A. Rudek5Nicole Anders6Chien-Fu Hung7Xiang Chen8Xiuxiu Lu9Olumide Kayode10Marzena Dyba11Kylie J. Walters12Richard B. S. Roden13†Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States†Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States†Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States‡Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States#Protein Processing Section, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States#Protein Processing Section, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States#Protein Processing Section, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States∇Biophysics Resource, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States#Protein Processing Section, Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States†Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United Stateshttp://dx.doi.org/10.1021/acsomega.8b01479 |
spellingShingle | Ravi K. Anchoori Rosie Jiang Shiwen Peng Ruey-shyang Soong Aliyah Algethami Michelle A. Rudek Nicole Anders Chien-Fu Hung Xiang Chen Xiuxiu Lu Olumide Kayode Marzena Dyba Kylie J. Walters Richard B. S. Roden Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer ACS Omega |
title | Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer |
title_full | Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer |
title_fullStr | Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer |
title_full_unstemmed | Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer |
title_short | Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer |
title_sort | covalent rpn13 binding inhibitors for the treatment of ovarian cancer |
url | http://dx.doi.org/10.1021/acsomega.8b01479 |
work_keys_str_mv | AT ravikanchoori covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT rosiejiang covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT shiwenpeng covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT rueyshyangsoong covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT aliyahalgethami covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT michellearudek covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT nicoleanders covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT chienfuhung covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT xiangchen covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT xiuxiulu covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT olumidekayode covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT marzenadyba covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT kyliejwalters covalentrpn13bindinginhibitorsforthetreatmentofovariancancer AT richardbsroden covalentrpn13bindinginhibitorsforthetreatmentofovariancancer |